1,813
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Initial symptoms and three months follow-up after acute COVID-19 in outpatients: An international prospective cohort study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2154074 | Received 12 May 2022, Accepted 03 Nov 2022, Published online: 19 Jan 2023

References

  • WHO: COVID-19 Explorer. World Health Organisation. [cited 2022 November 22] Available from: https://covid19.who.int/explorer.
  • World Health Organisation: Clinical management of COVID-19:interim guidance. 2020. World Health Organisation. [cited 2022 November 22] Available from: https://apps.who.int/iris/handle/10665/332196.
  • Mehta OP, Bhandari P, Raut A, et al. Coronavirus disease (COVID-19): comprehensive review of clinical presentation. Front Public Health. 2020;8:582932.
  • Whittaker HR, Gulea C, Koteci A, et al. GP consultation rates for sequelae after acute covid-19 in patients managed in the community or hospital in the UK: population based study. BMJ. 2021;375:e065834.
  • He X, Cheng X, Feng X, et al. Clinical symptom differences between mild and severe COVID-19 patients in China: a meta-analysis. Front Public Health. 2020;8:561264.
  • World Health Organisation: A clinical case definition of post COVID-19 condition by a Delphi consensus. World Health Organisation. [updated 2021 Oct 6; cited 22 Nov 2022] Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1
  • Groff D, Sun A, Ssentongo AE, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4(10):e2128568.
  • Van der Velden AW, Van de Pol AC, Bongard E, et al. Point-of-care testing, antibiotic prescribing, and prescribing confidence for respiratory tract infections in primary care: a prospective audit in 18 european countries. BJGP Open. 2022;6(2):BJGPO.2021.0212. BJGPO.2021.0212.
  • Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March–June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993–998.
  • Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626–631.
  • Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.
  • Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43–55.
  • Khandia R, Singhal S, Alqahtani T, et al. Emergence of SARS-CoV-2 omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic. Environ Res. 2022;209:112816.
  • Abdullah F, Myers J, Basu D, et al. Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, South Africa. Int J Infect Dis. 2022;116:38–42.
  • Kuodi PGY, Zayyad H, Wertheim O, et al. Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021. npj Vaccines. 2022;7(1):101.
  • Baraniuk C. Covid-19: how Europe is approaching long covid. BMJ. 2022;376:o158.